Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引:0
|
作者
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
关键词
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I
10.7759/cureus.9508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
    Eugenio Hinojosa-Gonzalez, David
    Davila-Gonzalez, Daniel
    Salgado-Garza, Gustavo
    Flores-Villalba, Eduardo
    LUNG INDIA, 2020, 37 (03) : 252 - 256
  • [22] Angioedema in renal transplant recipients on sirolimus
    Mahe, Emmanuel
    Morelon, Emmanuel
    Lechaton, Sophie
    Kreis, Henri
    de Prost, Yves
    Bodemer, Christine
    DERMATOLOGY, 2007, 214 (03) : 205 - 209
  • [23] An uncommon case of spontaneous hemopericardium in a patient treated with rivaroxaban
    Ioppolo, Anna Maria
    Longobardo, Luca
    D'Isa, Salvatore
    De Gregorio, Paola
    Manfredi, Mariella
    De Cesare, Nicoletta Bianca
    JOURNAL OF CARDIOVASCULAR ECHOGRAPHY, 2019, 29 (04) : 180 - 182
  • [24] Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
    Kahan, BD
    Yakupoglu, YK
    Schoenberg, L
    Knight, RJ
    Katz, SM
    Lai, D
    Van Buren, CT
    TRANSPLANTATION, 2005, 80 (06) : 749 - 758
  • [25] Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus
    Tainá Veras de Sandes Freitas
    Kelly Miyuki Harada
    Cláudia Rosso Felipe
    Nelson Zocoler Galante
    Edison Luiz Mandia Sampaio
    Edson Ikehara
    Fernando Alfieri
    Hélio Tedesco-Silva Júnior
    José Osmar Medina-Pestana
    International Urology and Nephrology, 2011, 43 : 1221 - 1228
  • [26] Clinical application of sirolimus in renal post-transplant patients
    潘晓鸣
    薛武军
    田普训
    丁小明
    Journal of Medical Colleges of PLA , 2006, (05) : 340 - 343
  • [27] Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus
    Chuang, P.
    Langone, A. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) : 714 - 717
  • [28] Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus
    de Sandes Freitas, Taina Veras
    Harada, Kelly Miyuki
    Felipe, Claudia Rosso
    Galante, Nelson Zocoler
    Mandia Sampaio, Edison Luiz
    Ikehara, Edson
    Alfieri, Fernando
    Tedesco-Silva Junior, Helio
    Medina-Pestana, Jose Osmar
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (04) : 1221 - 1228
  • [29] T-Cell Function Monitoring in Stable Renal Transplant Patients Treated with Sirolimus Monotherapy
    Mercè Brunet
    Josep Ma. Campistol
    Fritz Diekmann
    David Guillen
    Olga Millán
    Molecular Diagnosis & Therapy, 2007, 11 : 247 - 256
  • [30] Nanomedicines in renal transplant rejection - focus on sirolimus
    Shen, Li-Jiuan
    Wu, Fe-Lin Lin
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01): : 25 - 32